Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype.

Journal of the neurological sciences - 1 Oct 1995

Morandi L, Mora M, Confalonieri V, Barresi R, Di Blasi C, Brugnoni R, Bernasconi P, Mantegazza R, Dworzak F, Antozzi C

Abstract excerpt

We have investigated protein expression and genotype in 59 Becker muscular dystrophy (BMD) patients. The aim was to identify possible causes of the marked variability in phenotype in patients with similar deletions/mutations. The patients were examined neurologically and functionally and underwent Manual Muscle Testing. Dystrophin expression was analysed by immunohistochemistry and western blot using antibodies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Blotting, Western

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Gene Deletion

Share to Immunohistochemistry

Share to Molecular Weight

Source

Identifiers

PMID: 8543940
DOI: 10.1016/0022-510x(95)00147-t

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype.PMID 8543940Read ↗

Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.Semantic proximity Read ↗

Clinical, immunohistochemical, Western blot, and genetic analysis in dystrophinopathy.Semantic proximity Read ↗

Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.Semantic proximity Read ↗

[Genetics and molecular aspects of dystrophinopathies].Semantic proximity Read ↗

Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.Semantic proximity Read ↗

Unusual expression and very mild course of Xp21 muscular dystrophy (Becker type) in a 60-year-old man with 26 percent deletion of the dystrophin gene.Semantic proximity Read ↗

The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities.Semantic proximity Read ↗

Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy.Semantic proximity Read ↗

Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity.Semantic proximity Read ↗

Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.Semantic proximity Read ↗

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies.Semantic proximity Read ↗

Dystrophin levels and clinical severity in Becker muscular dystrophy patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.